19 Jul Akadeum Life Sciences
Brandon McNaughton, Ph.D., CEO & Co-founder
Oct. 8 | 9:15am | FLW Ballroom G
Ann Arbor, MI
(Private)
Akadeum Life Sciences is revolutionizing cell therapy separation workflows by enhancing quality of cells (better knockout efficiency), maximizing throughput, and by incorporating straightforward workflows. Akadeum’s new Alerion Microbubble Cell Separation System utilizes microbubble-based separation technology designed to provide the most gentle, fast, and high throughput instrument on the market. Akadeum’s flagship products focuses on the isolation of T cells for cell and gene therapy applications and are available as clinical ready GMP grade kits. Akadeum will be fully releasing the Alerion, providing automated capability for positive selection, negative selection, and depletion at scales previously not available in existing workflows.
